Net profit of Panacea Biotec declined 96.75% to Rs 0.43 crore in the quarter ended December 2023 as against Rs 13.24 crore during the previous quarter ended December 2022. Sales rose 32.32% to Rs 95.23 crore in the quarter ended December 2023 as against Rs 71.97 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales95.2371.97 32 OPM %6.9717.08 - PBDT6.2819.32 -67 PBT1.0713.24 -92 NP0.4313.24 -97 Powered by Capital Market - Live News

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 8 February 2024.Powered by Capital Market - Live News

Net loss of Panacea Biotec reported to Rs 8.29 crore in the quarter ended September 2023 as against net profit of Rs 15.70 crore during the previous quarter ended September 2022. Sales rose 36.05% to Rs 143.02 crore in the quarter ended September 2023 as against Rs 105.12 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales143.02105.12 36 OPM %-2.49-3.65 - PBDT-1.245.43 PL PBT-10.55-4.46 -137 NP-8.2915.70 PL Powered by Capital Market - Live News

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 10 November 2023.Powered by Capital Market - Live News